News
News-Medical.Net on MSN1d
Body image concerns drive interest in GLP-1 weight loss drugs, study findsA new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...
Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback